Track topics on Twitter Track topics that are important to you
EpiCast Report: Melanoma Epidemiology Forecast to 2026
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of skin. Melanoma is considered an aggressive form of cancer; however, if caught early, it can be treated very successfully. Melanoma is one of the most common cancer types in the US, and is considered the national cancer of Australia. Melanoma risk factors include increasing age, sex, fair complexion, excessive ultraviolet UV light exposure, history of sunburn, having many more than 50 moles, a personal history of cancer of the skin, a family history of melanoma, immunosuppression, and certain medical conditions including, but not limited to, xeroderma pigmentosum XP and atypical mole dysplastic nevi syndrome.
In the 7MM, GlobalData epidemiologists forecast the diagnosed incident cases of melanoma to increase from 165,651 cases in 2016 to 206,717 cases in 2026, at an Annual Growth Rate AGR of 2.48%. The US will have the highest number of melanoma cases throughout the forecast period. The fiveyear diagnosed prevalent cases of melanoma in the 7MM are also expected to increase from 724,704 cases in 2016 to 909,265 cases in 2026 at an AGR of 2.55%.
GlobalData's epidemiological forecast for the diagnosed incident and fiveyear diagnosed prevalent cases of Melanoma in the 7MM is supported by age and sexspecific incidence data drawn from national cancer registries. Additionally, the analysis is strengthened by the use of a consistent methodology across the 7MM for the diagnosed incident cases forecast, using regression techniques to evaluate trends, and is based on 10 years of countryspecific historical data points pertaining to the age and sexspecific diagnosed incidence of melanoma.
The Melanoma EpiCast Report provides an overview of the risk factors and global trends of melanoma in the 7MM US, France, Germany, Italy, Spain, UK, and Australia. It includes a 10year epidemiological forecast for the diagnosed incident cases and fiveyear diagnosed prevalent cases of melanoma segmented by age beginning at 18 years and ending at 80 years and older, sex, and cancer stage at diagnosis American Joint Commission on Cancer [AJCC] Stages I, II, III, and IV.
The melanoma epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The Melanoma EpiCast report will allow you to
Develop business strategies by understanding the trends shaping and driving the global melanoma market.
Quantify patient populations in the global melanoma market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for melanoma therapeutics in each of the markets covered.
Compare patient population potentials by age, sex, stage at diagnosis, and survival.NEXT ARTICLE
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...